Literature DB >> 24603791

A Fox of a different color: FoxA1 programs a new regulatory T cell subset.

Greg M Delgoffe1, Dario A A Vignali1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24603791     DOI： 10.1038/nm.3493

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  IFN-beta inhibits T cell activation capacity of central nervous system APCs.

Authors:  Ingrid Teige; Yawei Liu; Shohreh Issazadeh-Navikas
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

Review 2.  Emerging concepts in CD8(+) T regulatory cells.

Authors:  Jerry Y Niederkorn
Journal:  Curr Opin Immunol       Date:  2008-04-10       Impact factor: 7.486

3.  Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo.

Authors:  Stefan Lienenklaus; Marius Cornitescu; Natalia Zietara; Marcin Łyszkiewicz; Nelson Gekara; Jadwiga Jabłónska; Frank Edenhofer; Klaus Rajewsky; Dunja Bruder; Martin Hafner; Peter Staeheli; Siegfried Weiss
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

Review 4.  A critical appraisal of treatment decisions in multiple sclerosis--old versus new.

Authors:  Bernd C Kieseier; Olaf Stüve
Journal:  Nat Rev Neurol       Date:  2011-04-05       Impact factor: 42.937

Review 5.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

6.  IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.

Authors:  Ingrid Teige; Alexandra Treschow; Anna Teige; Ragnar Mattsson; Vaidrius Navikas; Tomas Leanderson; Rikard Holmdahl; Shohreh Issazadeh-Navikas
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

Review 7.  The Family of IL-10-secreting CD4+ T cells.

Authors:  Keishi Fujio; Tomohisa Okamura; Kazuhiko Yamamoto
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

8.  IL-35-mediated induction of a potent regulatory T cell population.

Authors:  Lauren W Collison; Vandana Chaturvedi; Abigail L Henderson; Paul R Giacomin; Cliff Guy; Jaishree Bankoti; David Finkelstein; Karen Forbes; Creg J Workman; Scott A Brown; Jerold E Rehg; Michael L Jones; Hsiao-Tzu Ni; David Artis; Mary Jo Turk; Dario A A Vignali
Journal:  Nat Immunol       Date:  2010-10-17       Impact factor: 25.606

Review 9.  Oncology meets immunology: the cancer-immunity cycle.

Authors:  Daniel S Chen; Ira Mellman
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

10.  FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS.

Authors:  Yawei Liu; Robert Carlsson; Manuel Comabella; Junyang Wang; Michael Kosicki; Belinda Carrion; Maruf Hasan; Xudong Wu; Xavier Montalban; Morten Hanefeld Dziegiel; Finn Sellebjerg; Per Soelberg Sørensen; Kristian Helin; Shohreh Issazadeh-Navikas
Journal:  Nat Med       Date:  2014-02-16       Impact factor: 53.440
  10 in total
  4 in total

Review 1.  Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells.

Authors:  Mark D Mannie; Kayla B DeOca; Alexander G Bastian; Cody D Moorman
Journal:  Cell Immunol       Date:  2020-07-15       Impact factor: 4.868

Review 2.  Relationship between CD4 Regulatory T Cells and Anergy In Vivo.

Authors:  Lokesh A Kalekar; Daniel L Mueller
Journal:  J Immunol       Date:  2017-04-01       Impact factor: 5.422

3.  Human interferon-ϵ and interferon-κ exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R.

Authors:  Bethany D Harris; Jessica Schreiter; Marc Chevrier; Jarrat L Jordan; Mark R Walter
Journal:  J Biol Chem       Date:  2018-08-31       Impact factor: 5.157

4.  Neuronal IFN-beta-induced PI3K/Akt-FoxA1 signalling is essential for generation of FoxA1+Treg cells.

Authors:  Yawei Liu; Andrea Marin; Patrick Ejlerskov; Louise Munk Rasmussen; Marco Prinz; Shohreh Issazadeh-Navikas
Journal:  Nat Commun       Date:  2017-04-24       Impact factor: 14.919
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.